open trial high-dosag antioxid earli parkinson diseas high dosag tocopherol ascorb patient earli parkinson diseas preliminari open-label trial eventu double-blind studi antioxid test endogen toxin hypothesi etiolog parkinson diseas primari endpoint trial need patient levodopa time levodopa necessari treat patient group patient antioxid time levodopa necessari group antioxid result pilot studi progress parkinson diseas administr antioxid larg multicent clinic trial north america tocopherol deprenyl potenti result 